Skip to content

Kumamoto cardiac amyloidosis survey

Kumamoto cardiac amyloidosis survey - Kumamoto cardiac amyloidosis survey

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000033471
Enrollment
100
Registered
2018-09-01
Start date
2018-06-26
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac amyloidosis

Interventions

None listed

Sponsors

Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Cardiac amyloidosis patients with 1)AL amyloidosis 2)Mutant ATTR amyloidosis 3)Wild type ATTR amyloidosis

Exclusion criteria

Exclusion criteria: A pregnant woman or pregnant patients

Design outcomes

Primary

MeasureTime frame
1)All cause death

Secondary

MeasureTime frame
1) Cardiovascular death and non cardiovascular death 2) Unplanned hospitalization due to worsening heart failure 3) Exacerbation of symptom 4) Change of treatment strategy 5) Change of laboratory and echocardiographic data

Countries

Japan

Contacts

Public ContactSeiji Takashio

Graduate School of Medical Sciences, Kumamoto University Department of Cardiovascular Medicine

s-takash@kumamoto-u.ac.jp096-373-5175

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026